Neutrophils: game changers in glomerulonephritis?

Trends in Molecular Medicine

Volumn 16, Issue 8, 2010, Pages 368-378

  Mayadas, Tanya N ^a   Rosetti, Florencia ^a   Ernandez, Thomas ^a   Sethi, Sanjeev ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; NEUTRAL PROTEINASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ADAPTIVE IMMUNITY; APOPTOSIS; CELL COMMUNICATION; CELL INFILTRATION; CELL INTERACTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; INFLAMMATION; KIDNEY BIOPSY; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW; T LYMPHOCYTE; THROMBOCYTE; TISSUE INJURY;

ANIMALS; DENDRITIC CELLS; GLOMERULONEPHRITIS; HUMANS; NEUTROPHILS; T-LYMPHOCYTES;

EID: 77955422625     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.06.002     Document Type: Review

References (126)

1. Javaid B., Quigg R.J. Treatment of glomerulonephritis: will we ever have options other than steroids and cytotoxics?. Kidney Int. 2005, 67:1692-1703.
2. Kurts C., et al. Role of T cells and dendritic cells in glomerular immunopathology. Semin. Immunopathol. 2007, 29:317-335.
3. Clatworthy M.R., Smith K.G. B cells in glomerulonephritis: focus on lupus nephritis. Semin. Immunopathol. 2007, 29:337-353.
4. Bagavant H., Fu S.M. Pathogenesis of kidney disease in systemic lupus erythematosus. Curr. Opin. Rheumatol. 2009, 21:489-494.
5. Tipping P.G., Holdsworth S.R. T cells in crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2006, 17:1253-1263.
6. Holdsworth S.R., Tipping P.G. Leukocytes in glomerular injury. Semin. Immunopathol. 2007, 29:355-374.
7. Camussi G., et al. The polymorphonuclear neutrophil (PMN) immunohistological technique: detection of immune complexes bound to the PMN membrane in acute poststreptococcal and lupus nephritis. Clin. Nephrol. 1980, 14:280-287.
8. Segerer S., et al. Expression of the chemokine receptor CXCR1 in human glomerular diseases. Kidney Int. 2006, 69:1765-1773.
9. Hooke D.H., et al. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int. 1987, 31:964-972.
10. Kanjanabuch T., et al. An update on acute postinfectious glomerulonephritis worldwide. Nat. Rev. Nephrol. 2009, 5:259-269.
11. Nasr S.H., et al. Acute postinfectious glomerulonephritis in the modern era: experience with 86 adults and review of the literature. Medicine (Baltimore) 2008, 87:21-32.
12. Alchi B., Jayne D. Membranoproliferative glomerulonephritis. Pediatr. Nephrol. 2010, 25:1409-1418.
13. Smith K.D., Alpers C.E. Pathogenic mechanisms in membranoproliferative glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 2005, 14:396-403.
14. Servais A., et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J. Med. Genet. 2007, 44:193-199.
15. Smith R.J., et al. New approaches to the treatment of dense deposit disease. J. Am. Soc. Nephrol. 2007, 18:2447-2456.
16. Sethi S., et al. Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway. Kidney Int. 2009, 75:952-960.
17. Fischer E.G., Lager D.J. Anti-glomerular basement membrane glomerulonephritis: a morphologic study of 80 cases. Am. J. Clin. Pathol. 2006, 125:445-450.
18. Xiao H., et al. The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am. J. Pathol. 2005, 167:39-45.
19. Jennette J.C., Falk R.J. Pathogenesis of the vascular and glomerular damage in ANCA-positive vasculitis. Nephrol. Dial. Transplant. 1998, 13(Suppl. 1):16-20.
20. Kain R., et al. Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models. Curr. Opin. Rheumatol. 2010, 22:15-20.
21. Sis B., et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am. J. Transplant. 2010, 10:464-471.
22. Harper L., Savage C.O. Pathogenesis of ANCA-associated systemic vasculitis. J. Pathol. 2000, 190:349-359.
23. Jennette J.C., Falk R.J. New insight into the pathogenesis of vasculitis associated with antineutrophil cytoplasmic autoantibodies. Curr. Opin. Rheumatol. 2008, 20:55-60.
24. Brouwer E., et al. Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int. 1994, 45:1120-1131.
25. Rarok A.A., et al. Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis. J. Am. Soc. Nephrol. 2002, 13:2232-2238.
26. von Vietinghoff S., Ley K. Homeostatic regulation of blood neutrophil counts. J. Immunol. 2008, 181:5183-5188.
27. Mayadas T.N., et al. Glomerular inflammation: use of genetically deficient mice to elucidate the roles of leukocyte adhesion molecules and Fc-gamma receptors in vivo. Curr. Opin. Nephrol. Hypertens. 1999, 8:293-298.
28. Cochrane C.G., et al. A role of polymorphonuclear leukocytes and complement in nephrotoxic nephritis. J. Exp. Med. 1965, 122:99-116.
29. Franchini M. Thrombotic microangiopathies: an update. Hematology 2006, 11:139-146.
30. Hirahashi J., et al. Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation 2009, 120:1255-1265.
31. Jennette J.C., et al. Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J. Am. Soc. Nephrol. 2006, 17:1235-1242.
32. Gan P.Y., et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J. Am. Soc. Nephrol. 2010, 21:925-931.
33. Tsuboi N., et al. Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases. Immunity 2008, 28:833-846.
34. Duffield J.S., et al. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am. J. Pathol. 2005, 167:1207-1219.
35. Liu K., Mohan C. What do mouse models teach us about human SLE?. Clin. Immunol. 2006, 119:123-130.
36. Teramoto K., et al. Microarray analysis of glomerular gene expression in murine lupus nephritis. J. Pharmacol. Sci. 2008, 106:56-67.
37. Bao L., et al. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist. Eur. J. Immunol. 2005, 35:2496-2506.
38. Zhang Z., et al. The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 2009, 183:3160-3169.
39. Bullard D.C., et al. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality. J. Immunol. 1997, 159:2058-2067.
40. Kevil C.G., et al. Loss of LFA-1, but not Mac-1, protects MRL/MpJ-Fas(lpr) mice from autoimmune disease. Am. J. Pathol. 2004, 165:609-616.
41. Pickering M.C., et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat. Genet. 2002, 31:424-428.
42. Pickering M.C., et al. Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9649-9654.
43. Kilgore K.S., et al. The membrane attack complex of complement induces interleukin-8 and monocyte chemoattractant protein-1 secretion from human umbilical vein endothelial cells. Am. J. Pathol. 1996, 149:953-961.
44. Kilgore K.S., et al. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 1995, 155:1434-1441.
45. Pastore Y., et al. An experimental model of cryoglobulin-associated vasculitis in mice. Springer Semin. Immunopathol. 2001, 23:315-329.
46. Fulpius T., et al. Polymorphonuclear leukocytes play a key role in the generation of " wire-loop" lesions induced by a murine IgG3 rheumatoid factor. Kidney Int. 1996, 49:647-655.
47. Ley K., et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
48. Kitching A.R., et al. Targeting leukocytes in immune glomerular diseases. Curr. Med. Chem. 2008, 15:448-458.
49. Rosenkranz A.R., et al. P-selectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J. Clin. Invest. 1999, 103:649-659.
50. Dunn, K.W. et al. (2007) Live-animal imaging of renal function by multiphoton microscopy. Curr. Protoc. Cytom. Chapter 12, Unit 12.9.
51. Stokol T., et al. C1q governs deposition of circulating immune complexes and leukocyte Fcgamma receptors mediate subsequent neutrophil recruitment. J. Exp. Med. 2004, 200:835-846.
52. Lauterbach M., et al. Role of TNF priming and adhesion molecules in neutrophil recruitment to intravascular immune complexes. J. Leukoc. Biol. 2008, 83:1423-1430.
53. Lister K.J., et al. Immune complexes mediate rapid alterations in microvascular permeability: roles for neutrophils, complement, and platelets. Microcirculation 2007, 14:709-722.
54. Mayadas T.N., et al. Mechanisms of immune complex-mediated neutrophil recruitment and tissue injury. Circulation 2009, 120:2012-2024.
55. He X., et al. Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J. Immunol. 2006, 177:8748-8756.
56. Anders H.J., et al. Questions about chemokine and chemokine receptor antagonism in renal inflammation. Nephron Exp. Nephrol. 2010, 114:e33-e38.
57. Tang T., et al. A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J. Exp. Med. 1997, 186:1853-1863.
58. Kuligowski M.P., et al. Antimyeloperoxidase antibodies rapidly induce alpha-4-integrin-dependent glomerular neutrophil adhesion. Blood 2009, 113:6485-6494.
59. Nolan S.L., et al. Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo. J. Am. Soc. Nephrol. 2008, 19:973-984.
60. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 2006, 6:173-182.
61. Mayadas T.N., Cullere X. Neutrophil beta2 integrins: moderators of life or death decisions. Trends Immunol. 2005, 26:388-395.
62. Fialkow L., et al. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 2007, 42:153-164.
63. Gaertner S.A., et al. Glomerular oxidative and antioxidative systems in experimental mesangioproliferative glomerulonephritis. J. Am. Soc. Nephrol. 2002, 13:2930-2937.
64. Heeringa P., et al. Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis. Kidney Int. 1998, 53:382-393.
65. Poelstra K., et al. Intraglomerular platelet aggregation and experimental glomerulonephritis. Kidney Int. 1990, 37:1500-1508.
66. Suzuki Y., et al. Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: potential role in the perpetuation of immune nephritis. J. Immunol. 2003, 170:3243-3253.
67. Budisavljevic M.N., et al. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am. J. Physiol. Renal Physiol. 2003, 285:F1138-1148.
68. Bondi C.D., et al. NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts. J. Am. Soc. Nephrol. 2010, 21:93-102.
69. Goto S., et al. Expression and localization of inducible nitric oxide synthase in anti-Thy-1 glomerulonephritis. Am. J. Pathol. 1995, 147:1133-1141.
70. Kuzniar J., et al. Elastase deposits in the kidney and urinary elastase excretion in patients with glomerulonephritis - evidence for neutrophil involvement in renal injury. Scand. J. Urol. Nephrol. 2007, 41:527-534.
71. Afshar-Kharghan V., Thiagarajan P. Leukocyte adhesion and thrombosis. Curr. Opin. Hematol. 2006, 13:34-39.
72. Mydel P., et al. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J. Biol. Chem. 2008, 283:9513-9522.
73. Cai T.Q., Wright S.D. Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha M beta 2) and modulates polymorphonuclear leukocyte adhesion. J. Exp. Med. 1996, 184:1213-1223.
74. Schrijver G., et al. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J. Exp. Med. 1989, 169:1435-1448.
75. Soehnlein O. An elegant defense: how neutrophils shape the immune response. Trends Immunol. 2009, 30:511-512.
76. Klebanoff S.J. Myeloperoxidase: friend and foe. J. Leukoc. Biol. 2005, 77:598-625.
77. Li J.Z., et al. Polymorphonuclear leukocytes increase glomerular albumin permeability via hypohalous acid. Kidney Int. 1994, 46:1025-1030.
78. Peppin G.J., Weiss S.J. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:4322-4326.
79. Odobasic D., et al. Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis. J. Am. Soc. Nephrol. 2007, 18:760-770.
80. Serhan C.N., et al. Anti-inflammatory and proresolving lipid mediators. Annu. Rev. Pathol. 2008, 3:279-312.
81. O'Meara Y.M., Brady H.R. Lipoxins, leukocyte recruitment and the resolution phase of acute glomerulonephritis. Kidney Int. Suppl. 1997, 58:S56-61.
82. Borregaard N., et al. Neutrophil granules: a library of innate immunity proteins. Trends Immunol. 2007, 28:340-345.
83. Scapini P., et al. The neutrophil as a cellular source of chemokines. Immunol. Rev. 2000, 177:195-203.
84. Cassatella M.A. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 1999, 73:369-509.
85. Kasama T., et al. Expression and regulation of human neutrophil-derived macrophage inflammatory protein 1 alpha. J. Exp. Med. 1993, 178:63-72.
86. Gasperini S., et al. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 1999, 162:4928-4937.
87. Molesworth-Kenyon S.J., et al. A novel role for neutrophils as a source of T cell-recruiting chemokines IP-10 and Mig during the DTH response to HSV-1 antigen. J. Leukoc. Biol. 2005, 77:552-559.
88. Muller I., et al. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms?. Trends Immunol. 2009, 30:522-530.
89. Boudaly S. Activation of dendritic cells by polymorphonuclear neutrophils. Front. Biosci. 2009, 14:1589-1595.
90. Proost P., et al. Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation. J. Exp. Med. 2008, 205:2085-2097.
91. Semple J.W., Freedman J. Platelets and innate immunity. Cell. Mol. Life Sci. 2010, 67:499-511.
92. Zachem C.R., et al. A role for P-selectin in neutrophil and platelet infiltration in immune complex glomerulonephritis. J. Am. Soc. Nephrol. 1997, 8:1838-1844.
93. Johnson R.J., et al. Mechanisms and kinetics for platelet and neutrophil localization in immune complex nephritis. Kidney Int. 1989, 36:780-789.
94. Ito I., et al. Effects of a new synthetic selectin blocker in an acute rat thrombotic glomerulonephritis. Am. J. Kidney Dis. 2001, 38:265-273.
95. Wu X., et al. Fibrinogen mediates platelet-polymorphonuclear leukocyte cooperation during immune-complex glomerulonephritis in rats. J. Clin. Invest. 1994, 94:928-936.
96. Manfredi A.A., et al. Dangerous connections: neutrophils and the phagocytic clearance of activated platelets. Curr. Opin. Hematol. 2010, 17:3-8.
97. Summers S.A., et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J. Am. Soc. Nephrol. 2009, 20:2518-2524.
98. Korn T., et al. IL-17 and Th17 Cells. Annu. Rev. Immunol. 2009, 27:485-517.
99. Romani L., et al. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. J. Immunol. 1997, 158:5349-5356.
100. Romani L., et al. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol. 1997, 158:2356-2362.
101. Grabie N., et al. Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am. J. Pathol. 2003, 163:2413-2420.
102. Iking-Konert C., et al. Polymorphonuclear neutrophils in Wegener's granulomatosis acquire characteristics of antigen presenting cells. Kidney Int. 2001, 60:2247-2262.
103. Iking-Konert C., et al. Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann. Rheum. Dis. 2005, 64:1436-1442.
104. Munder M., et al. Suppression of T-cell functions by human granulocyte arginase. Blood 2006, 108:1627-1634.
105. Zehntner S.P., et al. Neutrophils that infiltrate the central nervous system regulate T cell responses. J. Immunol. 2005, 174:5124-5131.
106. van Gisbergen K.P., et al. Close encounters of neutrophils and DCs. Trends Immunol. 2005, 26:626-631.
107. Ismail H.F., et al. Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J. Immunol. 2003, 170:3782-3789.
108. Tateda K., et al. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J. Immunol. 2001, 166:3355-3361.
109. Luo H.R., Loison F. Constitutive neutrophil apoptosis: mechanisms and regulation. Am. J. Hematol. 2008, 83:288-295.
110. Cabrini M., et al. New insights into the mechanisms controlling neutrophil survival. Curr. Opin. Hematol. 2010, 17:31-35.
111. Byrne A., Reen D.J. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J. Immunol. 2002, 168:1968-1977.
112. Stark M.A., et al. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
113. Huynh M.L., et al. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 2002, 109:41-50.
114. Lucas M., et al. Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J. Immunol. 2003, 171:2610-2615.
115. Clayton A.R., et al. Dendritic cell uptake of human apoptotic and necrotic neutrophils inhibits CD40, CD80, and CD86 expression and reduces allogeneic T cell responses: relevance to systemic vasculitis. Arthritis Rheum. 2003, 48:2362-2374.
116. Aleman M., et al. Spontaneous or Mycobacterium tuberculosis-induced apoptotic neutrophils exert opposite effects on the dendritic cell-mediated immune response. Eur. J. Immunol. 2007, 37:1524-1537.
117. Yousefi S., et al. Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps. Cell Death Differ. 2009, 16:1438-1444.
118. Neeli I., et al. Histone deimination as a response to inflammatory stimuli in neutrophils. J. Immunol. 2008, 180:1895-1902.
119. Kessenbrock K., et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 2009, 15:623-625.
120. Cullere X., et al. Neutrophil-selective CD18 silencing using RNA interference in vivo. Blood 2008, 111:3591-3598.
121. Braselmann S., et al. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. J. Pharmacol. Exp. Ther. 2006, 319:998-1008.
122. Pine P.R., et al. Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor. Clin. Immunol. 2007, 124:244-257.
123. Bahjat F.R., et al. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 2008, 58:1433-1444.
124. Weinblatt M.E., et al. Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial. Arthritis Rheum. 2008, 58:3309-3318.
125. Kyttaris V.C., Tsokos G.C. Syk kinase as a treatment target for therapy in autoimmune diseases. Clin. Immunol. 2007, 124:235-237.
126. Pietersz G.A., et al. Inhibition of destructive autoimmune arthritis in FcgammaRIIa transgenic mice by small chemical entities. Immunol. Cell Biol. 2009, 87:3-12.